SEC EDGAR Filings04/11 00:51 UTC4 - Martin Patricia A.Filed: 2026-04-10 AccNo: 0001193125-26-151626 Size: 4 KBInsider Ownership FilingANTXAN2 Therapeutics, Inc.U.S. Securities and Exchange Commission热度 106.4重要度 74情绪 0.00